BioSpace News Archive

Business

Premier’s ProvideGx™ Program to Supply Sodium Bicarbonate Injection to Providers

Premier Inc., through its ProvideGx™ program, has partnered with Exela Pharma Sciences, LLC, to supply sodium bicarbonate injection to healthcare providers, a drug that has been in shortage in the U.S. for nearly two years.

July 23, 2019
·
5 min read
Top 5 Vendors in the Transcatheter Embolization and Occlusion Devices Market from 2019 to 2023 | Technavio

The need for quality patient care has increased owing to the growing aging population and the consequent rise in chronic diseases.

July 23, 2019
·
5 min read
Pharm Country

Dr. Reddy’s Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market

Dr. Reddy’s Laboratories Ltd. announced the launch of Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem® (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

July 23, 2019
·
2 min read
Pharm Country

Use of Non-Hospital-Based Provider-to-Patient Telehealth Grew Nearly 1,400 Percent from 2014 to 2018

Increase Greater in Urban Than Rural Areas, FAIR Health Study Finds

July 23, 2019
·
6 min read
Business

Quest Diagnostics Reports Second Quarter 2019 Financial Results

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the second quarter ended June 30, 2019.

July 23, 2019
·
6 min read
FDA

Merck and Eisai Receive Third Breakthrough Therapy Designation from FDA for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment

Designation Granted for Potential First-Line Treatment of Patients with Advanced Unresectable Hepatocellular Carcinoma Not Amenable to Locoregional Treatment

July 23, 2019
·
51 min read
Deals

BD releases 2018 Sustainability Report

BD, a leading global medical technology company, issued its 2018 Sustainability Report, focusing on management of the environmental, social and governance factors that support the company’s 2020 Sustainability Goals.

July 23, 2019
·
4 min read
Policy

Alnylam Launches ONPATTRO® (patisiran) for the Treatment of Polyneuropathy in hATTR Amyloidosis, the First-Ever RNAi Therapeutic Approved in Canada

ONPATTRO® is the Only Treatment that Demonstrated Improvement, Relative to Baseline, in both Polyneuropathy and Quality of Life Measures in Patients1, 2 with hATTR Amyloidosis

July 23, 2019
·
11 min read
Business

Louisiana Implements Nurse Licensure Compact (NLC)

On July 1, 2019, Louisiana joined 30 other states in implementing the NLC, which allows for registered nurses and licensed practical/vocational nurses to have one multistate license, with the ability to practice in person or via telehealth, in both their home state and other NLC states.

July 23, 2019
·
2 min read
Deals

Avanos Medical, Inc. Announces Webcast of Second Quarter 2019 Financial Results Conference Call

Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the second quarter 2019 on Tuesday, Aug. 6 at 9 a.m. ET.

July 23, 2019
·
1 min read